Search Results

BioMidwest

VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting

VolitionRx Limited, a multi-national epigenetics company, has issued a mid-year review to stockholders, ahead of its Annual Meeting of Stockholders to be held on July 2, 2024.

June 27, 2024

·

5 min read

BioMidwest

VolitionRx Limited to Present at Jefferies 2024 Global Healthcare Conference

VolitionRx Limited, a multi-national epigenetics company, announced that Cameron Reynolds, President and Group Chief Executive Officer, will present and be available for one-to-one meetings at the Jefferies Global Healthcare Conference in New York City.

May 29, 2024

·

1 min read

Business

VolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update

VolitionRx Limited, a multi-national epigenetics company, announced financial results and a business update for the first quarter of 2024.

May 13, 2024

·

7 min read

Business

VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update

VolitionRx Limited announced it will host a conference call on Tuesday, May 14 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the first quarter 2024, in addition to providing a business update.

May 8, 2024

·

2 min read

Business

VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, today announced financial results and a business update for the full fiscal year ended December 31, 2023.

March 25, 2024

·

8 min read

Business

VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced it will host a conference call on Tuesday, March 26 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the fourth quarter and full year 2023, in addition to providing a business update.

March 21, 2024

·

2 min read

BioMidwest

VolitionRx Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie Entreprendre

VolitionRx Limited, a multi-national epigenetics company, has closed on an aggregate of Euro 5.0 million in financing from Wallonie Entreprendre S.A. in Belgium.

December 5, 2023

·

6 min read

Business

VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Update

VolitionRx Limited announced financial results and a business update for the third quarter ended September 30, 2023. Volition management will host a conference call tomorrow, November 15 at 8:30 a.m. U.S. Eastern Time to discuss these results.

November 14, 2023

·

7 min read

Business

VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business Update

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced it will host a conference call on Wednesday, November 15 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the third quarter 2023, in addition to providing a business update.

November 8, 2023

·

2 min read

Business

VolitionRx Limited Announces Second Quarter 2023 Financial Results and Business Update

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced financial results and a business update for the second quarter ended June 30, 2023.

August 14, 2023

·

7 min read